Viewing Study NCT04209881



Ignite Creation Date: 2024-05-06 @ 2:04 PM
Last Modification Date: 2024-10-26 @ 1:24 PM
Study NCT ID: NCT04209881
Status: COMPLETED
Last Update Posted: 2020-05-22
First Post: 2019-12-19

Brief Title: Ovarian Reserve and Ankylosing Spondylitis
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
Organization: Kanuni Sultan Suleyman Training and Research Hospital

Study Overview

Official Title: Evaluation of Ovarian Reserve Using Anti-müllerian Hormone and Antral Follicle Count in Ankylosing Spondylitis Preliminary Study
Status: COMPLETED
Status Verified Date: 2020-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study was to determine the status of ovarian reserve in patients with ankylosing spondylitis AS using anti-mullerian hormone AMH level and antral follicle count AFC Women with AS and women controls diagnosed according to the classification criteria proposed by the American-European Consensus Group will be included in the study Ovarian reserve will be evaluated in terms of clinical findings AFC and serum AMH and reproductive hormone levels

Researchers predict that the ovarian reserve may be reduced in patients with AS due to the autoimmune process and the pathophysiology of the disease Serum AMH and ovarian AFC may be useful for assessing ovarian reserve It is aimed to determine the course of ovarian reserve abnormalities and the best possible biomarkers of reduced ovarian reserve in patients with AS
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None